ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Endra Life Sciences Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.373 Good day and welcome to the NDRA Life Sciences third quarter 2023 00:00:05.373 -- 00:00:11.298 financial results conference call. All participants will be in a listen only mode. 00:00:11.298 -- 00:00:15.061 Should you need assistance, please signal a conference specialist by pressing the star 00:00:15.061 -- 00:00:17.303 key followed by zero. 00:00:17.303 -- 00:00:21.567 After today's presentation, there will be an opportunity to ask questions. 00:00:21.567 -- 00:00:25.890 To ask a question, you may press star then one on your touch tone phone. 00:00:25.890 -- 00:00:29.608 To withdraw your question, please press star then two. 00:00:29.608 -- 00:00:33.830 Please note this event is being recorded. I would now like to turn the conference over 00:00:33.830 -- 00:00:37.131 to Yvonne Briggs. Please go ahead. 00:00:37.131 -- 00:00:40.533 Thank you, Operator. This is Yvonne Briggs with LHA. 00:00:40.533 -- 00:00:44.114 Good afternoon and welcome to NDRA's third quarter 2023 00:00:44.114 -- 00:00:47.316 Business Update and Financial Results Conference Call. 00:00:47.316 -- 00:00:52.198 Earlier today, NDRA issued a press release on this topic, which is available in the Investors 00:00:52.198 -- 00:00:57.340 section of NDRA's website. Before we begin, please note that today's discussion 00:00:57.340 -- 00:01:02.337 will include forward-looking statements. All statements by management other than statements 00:01:02.337 -- 00:01:06.899 of historical facts, including statements regarding the company's strategies, financial 00:01:06.899 -- 00:01:11.902 condition, operations, costs, plans and objectives, as well as 00:01:11.902 -- 00:01:16.985 anticipated results of development and commercialization efforts, the timing of clinical 00:01:16.985 --...